Biomedicines (Oct 2023)

Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease

  • Guillermo Gervasini,
  • Zoraida Verde,
  • Luz M. González,
  • Celia Chicharro,
  • Laura González-Rodríguez,
  • Ana Fernández-Araque,
  • Sonia Mota-Zamorano,
  • Bárbara Cancho,
  • Alberto Pérez-Hernández,
  • Virginio García-López,
  • Fernando Bandrés,
  • Nicolás R. Robles

DOI
https://doi.org/10.3390/biomedicines11102775
Journal volume & issue
Vol. 11, no. 10
p. 2775

Abstract

Read online

There is a pressing need for more precise biomarkers of chronic kidney disease (CKD). Plasma samples from 820 subjects [231 with CKD, 325 with end-stage kidney disease (ESKD) and 264 controls] were analyzed by liquid chromatography with tandem mass spectrometry (LC-MS/MS) to determine a metabolic profile of 28 amino acids (AAs) and biogenic amines to test their value as markers of CKD risk and progression. The kynurenine/tryptophan ratio showed the strongest correlation with estimated glomerular filtration rate values (coefficient = −0.731, p p p p p < 0.0001). Plasma concentrations of AAs and related amines may be useful as diagnostic biomarkers of kidney disease, both for CKD risk and for progression of CKD patients to ESKD.

Keywords